ArticleOncotarget2016

Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.

Peng-Zhou Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.